CMFRI signs MoU to launch product from seaweeds to combat fatty liver disease The Print dated 20th December 2022
CMFRI Repository
View Archive InfoField | Value | |
Relation |
http://eprints.cmfri.org.in/16554/
https://theprint.in/india/cmfri-signs-mou-to-launch-product-from-seaweeds-to-combat-fatty-liver-disease/1272891/ |
|
Title |
CMFRI signs MoU to launch product from seaweeds to combat fatty liver disease The Print dated 20th December 2022
|
|
Creator |
CMFRI, Library
|
|
Subject |
CMFRI News Clippings
|
|
Description |
The Central Marine Fisheries Research Institute (CMFRI)has signed an MoU for the production of Cadalmin LivCure extract, a patent-protected nutraceutical product from seaweeds, to combat non-alcoholic fatty liver disease (NAFLD). A Memorandum of Understanding (MoU) was inked with Emineotech, a private limited company dealing with health products, for commercial production and marketing.
|
|
Publisher |
The Print
|
|
Date |
2022
|
|
Type |
Article
PeerReviewed |
|
Format |
text
|
|
Language |
en
|
|
Identifier |
http://eprints.cmfri.org.in/16554/1/The%20Print_20-12-2022.pdf
CMFRI, Library (2022) CMFRI signs MoU to launch product from seaweeds to combat fatty liver disease The Print dated 20th December 2022. The Print. |
|